Holen Sie sich die Stockscreener-App
6.53
4.53%
-0.31
Schlusskurs vom Vortag:
$6.84
Offen:
$6.9
24-Stunden-Volumen:
1.78M
Relative Volume:
0.89
Marktkapitalisierung:
$726.53M
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-4.9098
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
-5.91%
1M Leistung:
-3.40%
6M Leistung:
+231.47%
1J Leistung:
-34.70%
1-Tages-Spanne:
$6.51
$6.90
1-Wochen-Bereich:
$6.25
$7.15
52-Wochen-Spanne:
$1.03
$10.85
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie TNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.53 | 707.62M | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Will Tango Therapeutics Inc. rebound enough to break evenShort Setup & Safe Entry Momentum Stock Tips - newser.com
Earnings visualization tools for Tango Therapeutics Inc.Market Trend Report & AI Optimized Trading Strategy Guides - newser.com
Analysts Set Tango Therapeutics, Inc. (NASDAQ:TNGX) Price Target at $10.50 - Defense World
How to integrate Tango Therapeutics Inc. into portfolio analysis toolsJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Quantitative breakdown of Tango Therapeutics Inc. recent moveWeekly Market Report & High Accuracy Investment Signals - newser.com
Regression analysis insights on Tango Therapeutics Inc. performance2025 Stock Rankings & Technical Pattern Based Signals - newser.com
Custom strategy builders for tracking Tango Therapeutics Inc.2025 Dividend Review & Real-Time Volume Analysis Alerts - newser.com
Is Tango Therapeutics Inc. reversing from oversold territoryMarket Performance Report & AI Based Trade Execution Alerts - newser.com
Multi factor analysis applied to Tango Therapeutics Inc.Quarterly Portfolio Report & Weekly High Conviction Ideas - newser.com
Real time social sentiment graph for Tango Therapeutics Inc.Weekly Investment Report & Fast Momentum Entry Tips - newser.com
Chart based analysis of Tango Therapeutics Inc. trendsWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
What to expect from Tango Therapeutics Inc. in the next 30 daysWeekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Published on: 2025-09-14 09:27:48 - newser.com
Published on: 2025-09-14 09:20:27 - newser.com
Jacobs Levy Equity Management Inc. Purchases 220,529 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat
Will Tango Therapeutics Inc. stock recover after recent dropPortfolio Risk Report & Real-Time Volume Spike Alerts - newser.com
What MACD signals say about Tango Therapeutics Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - newser.com
Using economic indicators to assess Tango Therapeutics Inc. potential2025 Investor Takeaways & Community Consensus Picks - newser.com
Is now a turning point for Tango Therapeutics Inc.Market Sentiment Review & Safe Capital Allocation Plans - newser.com
News impact scoring models applied to Tango Therapeutics Inc.Weekly Investment Recap & Community Supported Trade Ideas - Newser
Institutional scanner results for Tango Therapeutics Inc.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Technical analysis overview for Tango Therapeutics Inc. stock2025 Year in Review & Fast Entry High Yield Stock Tips - Newser
Will Tango Therapeutics Inc. continue its uptrendQuarterly Risk Review & Weekly Momentum Stock Picks - Newser
What MACD and RSI say about Tango Therapeutics Inc.July 2025 News Drivers & Reliable Volume Spike Alerts - Newser
Can machine learning forecast Tango Therapeutics Inc. recoveryBuy Signal & Weekly Stock Performance Updates - Newser
Using Python tools to backtest Tango Therapeutics Inc. strategiesWeekly Profit Report & AI Based Buy and Sell Signals - Newser
Applying Wyckoff theory to Tango Therapeutics Inc. stockTrade Risk Summary & Reliable Entry Point Trade Alerts - Newser
Can momentum traders help lift Tango Therapeutics Inc.Quarterly Profit Summary & Fast Momentum Entry Tips - Newser
Tango Therapeutics (NASDAQ:TNGX) Trading Down 6.7% on Insider Selling - MarketBeat
Tools to assess Tango Therapeutics Inc.’s risk profileWeekly Gains Summary & Step-by-Step Swing Trade Plans - Newser
Tango Therapeutics Inc. stock daily chart insightsPortfolio Risk Report & Reliable Entry Point Trade Alerts - Newser
Real time breakdown of Tango Therapeutics Inc. stock performance2025 Growth vs Value & Smart Allocation Stock Reports - Newser
Will earnings trigger a reversal in Tango Therapeutics Inc.Earnings Risk Summary & Smart Investment Allocation Insights - Newser
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):